Skip to main content

Full-thickness macular hole stage four

A 68 years old lady systematically free presented with symptoms of distorted vision three months ago on her left with BCVA counting fingers and BCVA in the right eye is 20/20.


Clinical examination of her left eye shows the anterior and posterior segment unremarkable. In contrast, in her right eye, the anterior segment exam is unremarkable. Her fundus exam shows myopic changes with completed posterior PVD abnormal foveal reflex.


Fundus image


Fundus colored photograph shows myopic changes of the posterior pole with macular hole formation and yellow deposits.


Fundus image showing full-thickness macular hole
Fundus image showing full-thickness macular hole 


Optical coherence tomography


OCT scan shows an absence of operculum along with complete posterior vitreous detachment.

OCT features full-thickness foveal defect with increased thickness of surrounding tissue with the cystic formation and some RPE deposits the width of the hole is 732 microns while the height is 522 microns.


OCT cross-section showing stage four full-thickness macular hole
OCT cross-section showing stage four full-thickness macular hole

The enface image in the level of Vitreous/ILM shows a central hole at the fovea with tissue defect


EnFace OCT in the level of Vitreous/ILM featuring macular hole
EnFace OCT in the level of Vitreous/ILM featuring macular hole



Diagnosis: Macular Full-thickness hole stage 4


Management is pars plana vitrectomy with ILM peeling with a guarded prognosis.


Discussion


Vitreomacular traction (VMT) is the main pathological factor of a full-thickness macular hole. However, it can be combined with an epiretinal membrane, especially in stage three or four.


Full-thickness macular hole presented in 4 stages


Stage 1 features VMT with a defect in outer retinal layers; on clinical examination, the fundus looks like a yellow dot in the fovea center.

Stage 1b there would be VMT with a defect in the outer and inner retinal layers but not a full-thickness sparing the ILM, and clinically features a yellow circle at the center of the fovea. 

Stage 2 would be a full-thickness macular hole (FTMH) usually less than 400 microns with an attached operculum with or without vitreous traction. 

Stage 3, where there is FTMH with a detached operculum and can be 400 microns and more and features pseudo cystic changes along with tea table configuration of the surrounding tissue with attached posterior vitreous on the optic disc.

 Stage 4, the PVD is complete where Weiss ring can be noticed in clinical examination, and the hole is always larger than 400 microns.


Management of macular hole can be ranged from observation in stage one, which can close spontaneously in 50% of cases. Stage 2 can respond to pharmacological or pneumo vitreolysis in cases with small holes with persistent vitreous attachment. 

Stage 3 and 4 require Pars plana vitrectomy with ILM peeling. Some refractory cases may require inverted flap technique or autologous retinal transplant in cases of refractory macular holes in high myopic eyes and when the macular hole is larger than 1000μm.


Check clinical guidelines for macular hole


Comments

  1. Very nice information, This information will always help everyone for gaining knowledge. So please always share your important information. I am very thankful to you for providing essential information. yorktown eye doctor

    ReplyDelete
  2. You have mentioned here great information here. I would like to say this is a well-informed article and also beneficial article for us. Keep sharing this kind of articles, Thank you.Pterygium Surgery Recovery

    ReplyDelete

Post a Comment

Popular posts from this blog

Cellophane maculopathy

Caused by an epiretinal membrane, clinically, it appears as a sheen abnormal foveal reflex which features epiretinal membrane, due to inflammatory mediators and proliferation of glial cells secondary to a partial separation of posterior cortical vitreous. Fundus image shows cellophane maculopathy OCT features a hyperreflective band covering the inner retinal layers, causing minimal disturbance of inner retinal tissues. OCT cross-section shows epiretinal membrane  Cellophane maculopathy itself in individuals with good visual acuity may not need any interventions, but it is warranted to do a detailed peripheral retinal exam to rule out retinal tear or hole However, an epiretinal membrane may proliferate further and cause additional tangential traction. Thus, it may induce macular pucker or lamellar/pseudo hole and increase disturbance of inner retinal tissues, macular thickness, and reduction of vision. These patients may require pars plana vitrectomy to remove the epiretinal membrane an

RPE tear, and it's OCT features in a nutshell

RPE tear can occur in vascularized PEDs due to a complication of intravitreal AntiVEGF treatment, which causes a rapid contraction of CNVm, inducing traction on the RPE surface and shrinking of RPE surface. On OCT, the RPE rip will indent the retina with increased hyperreflectivity in contracted RPE with underlying shadowing hinders choroidal view in contrast to the area where RPE where it ripped of which only Bruch's membrane is visible and increasing the visibility of the underlying choroid. RPE tear Thus two opposite forces, the regression of CNVm and remaining attached RPE, other causes such as laser or spontaneous can occur. However, the AntiVEGF treatment continued despite the RPE tear. Please check  Clinical guidelines for ARMD  and  course of clinical changes in RPE

Sectoral retinitis pigmentosa

Sectoral retinitis pigmentosa is an autosomal dominant and usually associated with acceptable visual acuity.  The fundus examination shows pigment clumps and chorioretinal atrophy only in sectoral with almost normal optic disc configuration and vessel diameter. Fundus image showing Sectoral retinitis pigmentosa The sectoral retinitis pigmentosa symmetrical in both eyes Perimetry will show scotoma corresponding to the dispersion of pigmentary clumps. OCT shows outer retinal degeneration and RPE thining in the area of pigmentary clumps. Please check  Clinical guidelines in retinitis pigmentosa